HRP20020345B1 - Ciclesonide-containing aqueous pharmaceutical composition - Google Patents

Ciclesonide-containing aqueous pharmaceutical composition

Info

Publication number
HRP20020345B1
HRP20020345B1 HR20020345A HRP20020345A HRP20020345B1 HR P20020345 B1 HRP20020345 B1 HR P20020345B1 HR 20020345 A HR20020345 A HR 20020345A HR P20020345 A HRP20020345 A HR P20020345A HR P20020345 B1 HRP20020345 B1 HR P20020345B1
Authority
HR
Croatia
Prior art keywords
ciclesonide
pharmaceutical composition
aqueous pharmaceutical
containing aqueous
hydroxypropylmethylcellulose
Prior art date
Application number
HR20020345A
Other languages
English (en)
Croatian (hr)
Inventor
Nagano Atsuhiro
Nishibe Yoshihisa
Takanashi Kazuya
Original Assignee
Altana Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=17856339&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HRP20020345(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Altana Pharma Ag filed Critical Altana Pharma Ag
Publication of HRP20020345A2 publication Critical patent/HRP20020345A2/xx
Publication of HRP20020345B1 publication Critical patent/HRP20020345B1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/14—Quaternary ammonium compounds, e.g. edrophonium, choline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • A61P5/44—Glucocorticosteroids; Drugs increasing or potentiating the activity of glucocorticosteroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • A61P5/46—Drugs for disorders of the endocrine system of the suprarenal hormones for decreasing, blocking or antagonising the activity of glucocorticosteroids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Inorganic Chemistry (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
HR20020345A 1999-10-20 2002-04-19 Ciclesonide-containing aqueous pharmaceutical composition HRP20020345B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP29818699 1999-10-20
PCT/JP2000/007351 WO2001028563A1 (en) 1999-10-20 2000-10-20 Ciclesonide-containing aqueous pharmaceutical composition

Publications (2)

Publication Number Publication Date
HRP20020345A2 HRP20020345A2 (en) 2005-10-31
HRP20020345B1 true HRP20020345B1 (en) 2006-12-31

Family

ID=17856339

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20020345A HRP20020345B1 (en) 1999-10-20 2002-04-19 Ciclesonide-containing aqueous pharmaceutical composition

Country Status (36)

Country Link
US (2) US8383611B1 (sl)
EP (1) EP1227817B1 (sl)
JP (1) JP4856338B2 (sl)
KR (1) KR100705372B1 (sl)
CN (1) CN1198623C (sl)
AR (1) AR026073A1 (sl)
AT (1) ATE270107T1 (sl)
AU (1) AU776587B2 (sl)
BG (1) BG65799B1 (sl)
BR (1) BRPI0014880B8 (sl)
CA (1) CA2388325C (sl)
CO (1) CO5251406A1 (sl)
CZ (1) CZ297780B6 (sl)
DE (1) DE60011924T2 (sl)
DK (1) DK1227817T3 (sl)
EA (1) EA005201B1 (sl)
ES (1) ES2223595T3 (sl)
HK (1) HK1051003A1 (sl)
HR (1) HRP20020345B1 (sl)
HU (1) HU228894B1 (sl)
IL (2) IL148725A0 (sl)
ME (1) ME00568B (sl)
MX (1) MXPA02003975A (sl)
MY (1) MY121175A (sl)
NO (1) NO327379B1 (sl)
NZ (1) NZ518299A (sl)
PE (1) PE20010713A1 (sl)
PL (1) PL197537B1 (sl)
PT (1) PT1227817E (sl)
RS (1) RS50345B (sl)
SI (1) SI1227817T1 (sl)
SK (1) SK286194B6 (sl)
TR (1) TR200200831T2 (sl)
TW (1) TWI269655B (sl)
WO (1) WO2001028563A1 (sl)
ZA (1) ZA200203078B (sl)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR026073A1 (es) * 1999-10-20 2002-12-26 Nycomed Gmbh Composicion farmaceutica acuosa que contiene ciclesonida
US8182824B2 (en) * 2002-07-02 2012-05-22 Nycomed Gmbh Ciclesonide-containing sterile aqueous suspension
ATE472329T1 (de) 2002-08-30 2010-07-15 Nycomed Gmbh Verwendung der kombination von ciclesonid und antihistaminika zur behandlung von allergischer rhinitis
ES2312844T3 (es) 2002-12-12 2009-03-01 Nycomed Gmbh Medicamento de combinacion de r, r-formoterol y ciclesonida.
MY143936A (en) 2003-03-27 2011-07-29 Nycomed Gmbh Process for preparing crystalline ciclesonide with defined particle size
ES2452691T5 (es) 2003-09-16 2022-09-14 Covis Pharma Gmbh Uso de ciclesonida para el tratamiento de enfermedades respiratorias
PE20050941A1 (es) * 2003-12-16 2005-11-08 Nycomed Gmbh Suspensiones acuosas de ciclesonida para nebulizacion
US20080008762A1 (en) * 2004-11-17 2008-01-10 Government Of The Us, As Represented By The Secretary, Department Of Health And Human Services Steroid Formulation And Methods Of Treatment Using Same
JP5661985B2 (ja) 2006-12-27 2015-01-28 帝人ファーマ株式会社 無菌性水性懸濁製剤
EP2262506B1 (en) 2008-03-11 2014-05-07 Alcon Research, Ltd. Low viscosity, highly flocculated triamcinolone acetonide suspensions for intravitreal injection
US11007150B2 (en) 2011-08-18 2021-05-18 Covis Pharma Gmbh Pharmaceutical aerosol product for administration by oral or nasal inhalation

Family Cites Families (58)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4271143A (en) 1978-01-25 1981-06-02 Alcon Laboratories, Inc. Sustained release ophthalmic drug dosage
CH657779A5 (de) 1982-10-05 1986-09-30 Sandoz Ag Galenische zusammensetzungen enthaltend calcitonin.
IL70489A0 (en) 1982-12-29 1984-03-30 Armour Pharma Pharmaceutical compositions containing calcitonin
JPS59163313A (ja) 1983-03-09 1984-09-14 Teijin Ltd 経鼻投与用ペプチドホルモン類組成物
WO1985002092A1 (en) 1983-11-14 1985-05-23 Bio-Mimetics Inc. Bioadhesive compositions and methods of treatment therewith
GB8515132D0 (en) 1985-06-14 1985-07-17 British Nuclear Fuels Plc Measuring photosynthetic activities of plants
US5179079A (en) 1986-12-16 1993-01-12 Novo Nordisk A/S Nasal formulation and intranasal administration therewith
MY102411A (en) 1986-12-23 1992-06-17 Ciba Geigy Ag Nasal solutions
JPH0744940B2 (ja) 1986-12-24 1995-05-17 ライオン株式会社 口腔貼付用基材
US4802967A (en) 1987-04-08 1989-02-07 Andus Corporation Surface treatment of polymers
JPS63303931A (ja) 1987-06-05 1988-12-12 Sumitomo Pharmaceut Co Ltd 経鼻投与用成長ホルモン放出活性物質製剤
US4788220A (en) 1987-07-08 1988-11-29 American Home Products Corporation (Del.) Pediatric ibuprofen compositions
US5188826A (en) 1988-02-08 1993-02-23 Insite Vision Incorporated Topical ophthalmic suspensions
US5192535A (en) 1988-02-08 1993-03-09 Insite Vision Incorporated Ophthalmic suspensions
US5776493A (en) 1989-07-14 1998-07-07 Alza Corporation Oral osmotic device for delivery of nystatin with hydrogel driving member
DK0431719T3 (da) 1989-10-31 1995-02-27 Columbia Lab Inc Vaginalt vævsbefugtende præparat
US5147654A (en) 1990-07-23 1992-09-15 Alza Corporation Oral osmotic device for delivering nicotine
JPH078806B2 (ja) 1990-08-16 1995-02-01 旭化成工業株式会社 カルシトニン類含有経鼻投与用乳剤
GB9102579D0 (en) 1991-01-24 1991-03-27 Glaxo Group Ltd Compositions
GB9103824D0 (en) 1991-02-23 1991-04-10 Fisons Ag Formulation
CA2107587C (en) 1991-04-03 2004-11-23 Rudolph M. Kiemowitz Suppression of thromboxane levels by percutaneous administration of aspirin
IT1250691B (it) * 1991-07-22 1995-04-21 Giancarlo Santus Composizioni terapeutiche per somministrazione intranasale comprendenti ketorolac.
US5200195A (en) 1991-12-06 1993-04-06 Alza Corporation Process for improving dosage form delivery kinetics
JP2860729B2 (ja) 1992-03-10 1999-02-24 エスエス製薬株式会社 プラノプロフェン懸濁シロップ剤
CA2101126A1 (en) 1992-08-03 1994-02-04 Yasushi Morita Preparation for local treatment
JP3047948B2 (ja) 1992-12-07 2000-06-05 株式会社ツムラ ペプチド類経鼻投与用組成物
US5340572A (en) 1993-02-08 1994-08-23 Insite Vision Incorporated Alkaline ophthalmic suspensions
US5409703A (en) 1993-06-24 1995-04-25 Carrington Laboratories, Inc. Dried hydrogel from hydrophilic-hygroscopic polymer
JP2787131B2 (ja) 1993-07-30 1998-08-13 千寿製薬株式会社 水性懸濁液剤
US5540930A (en) 1993-10-25 1996-07-30 Pharmos Corporation Suspension of loteprednol etabonate for ear, eye, or nose treatment
JP3781792B2 (ja) 1993-12-27 2006-05-31 千寿製薬株式会社 ジフルプレドナート含有点眼用懸濁液剤
JPH07188059A (ja) 1993-12-28 1995-07-25 Rohto Pharmaceut Co Ltd 歯周病治療剤
RU2102979C1 (ru) 1994-07-18 1998-01-27 Панкрушева Татьяна Александровна Средство для лечения гнойно-воспалительных процессов кожи и слизистых оболочек различной этиологии
US5726181A (en) 1995-06-05 1998-03-10 Bionumerik Pharmaceuticals, Inc. Formulations and compositions of poorly water soluble camptothecin derivatives
WO1997001337A1 (en) 1995-06-29 1997-01-16 Mcneil-Ppc, Inc. The combination of topical nasal antihistamines and topical nasal steroids
JP3098401B2 (ja) 1995-07-12 2000-10-16 株式会社エルティーティー研究所 経鼻投与用製剤
JP2791317B2 (ja) 1995-12-26 1998-08-27 株式会社三和化学研究所 多層フィルム製剤
PT943326E (pt) 1996-02-27 2003-12-31 Teijin Ltd Composicao em po para administracao nasal
US5976573A (en) 1996-07-03 1999-11-02 Rorer Pharmaceutical Products Inc. Aqueous-based pharmaceutical composition
US5955097A (en) 1996-10-18 1999-09-21 Virotex Corporation Pharmaceutical preparation applicable to mucosal surfaces and body tissues
IT1286496B1 (it) 1996-11-20 1998-07-15 Leetrim Ltd Dublin Composizione farmaceutica orale ad attivita' antipiretica,analgesica ed antiinfiammatoria
SE9604486D0 (sv) 1996-12-05 1996-12-05 Astra Ab Novel formulation
FR2756739B1 (fr) 1996-12-05 2000-04-28 Astra Ab Nouvelle formulation de budesonide
TW503113B (en) 1997-01-16 2002-09-21 Senju Pharma Co Aqueous suspension for nasal administration
US6120752A (en) * 1997-05-21 2000-09-19 3M Innovative Properties Company Medicinal aerosol products containing formulations of ciclesonide and related steroids
JPH1121229A (ja) 1997-06-30 1999-01-26 Kyoto Yakuhin Kogyo Kk 抗真菌性外用製剤およびその製造方法
JP3386348B2 (ja) 1997-10-30 2003-03-17 帝人株式会社 鼻腔内投与用水性懸濁製剤
JP3386349B2 (ja) 1997-10-30 2003-03-17 帝人株式会社 水性懸濁医薬品組成物
JPH11130658A (ja) 1997-10-30 1999-05-18 Teijin Ltd 水性懸濁医薬品組成物
SE9704186D0 (sv) * 1997-11-14 1997-11-14 Astra Ab New composition of matter
CN1158995C (zh) 1998-01-22 2004-07-28 参天制药株式会社 氟米龙眼用混悬液
SE514128C2 (sv) * 1998-03-17 2001-01-08 Pharmalink Ab Användning av en glukokortikoid för framställning av ett läkemedel för behandling av glomerulonefrit
TWI243687B (en) 1998-04-21 2005-11-21 Teijin Ltd Pharmaceutical composition for application to mucosa
US6124268A (en) * 1999-02-17 2000-09-26 Natreon Inc. Natural antioxidant compositions, method for obtaining same and cosmetic, pharmaceutical and nutritional formulations thereof
RU11829U1 (ru) 1999-05-05 1999-11-16 Специальное конструкторское бюро транспортного машиностроения (ОАО Спецмаш) Рабочая площадка для буровых установок
CA2356177A1 (en) 1999-10-20 2001-04-26 Kazuya Takanashi Aqueous pharmaceutical compositions
AR026073A1 (es) * 1999-10-20 2002-12-26 Nycomed Gmbh Composicion farmaceutica acuosa que contiene ciclesonida
AR026072A1 (es) 1999-10-20 2002-12-26 Nycomed Gmbh Composicion farmaceutica que contiene ciclesonida para aplicacion a la mucosa

Also Published As

Publication number Publication date
JP2003512330A (ja) 2003-04-02
EP1227817B1 (en) 2004-06-30
PT1227817E (pt) 2004-11-30
CN1198623C (zh) 2005-04-27
IL148725A (en) 2006-12-31
MXPA02003975A (es) 2003-09-25
EP1227817A1 (en) 2002-08-07
RS50345B (sr) 2009-11-10
SK286194B6 (sk) 2008-05-06
IL148725A0 (en) 2002-09-12
BR0014880A (pt) 2002-06-11
BRPI0014880B1 (pt) 2015-08-11
BRPI0014880B8 (pt) 2021-05-25
ATE270107T1 (de) 2004-07-15
SK6932002A3 (en) 2002-09-10
CZ20021284A3 (cs) 2002-07-17
TR200200831T2 (tr) 2002-07-22
CA2388325C (en) 2007-09-18
NO327379B1 (no) 2009-06-22
US20130095146A1 (en) 2013-04-18
EA005201B1 (ru) 2004-12-30
DK1227817T3 (da) 2004-11-15
YU28102A (sh) 2004-12-31
SI1227817T1 (sl) 2004-12-31
EA200200383A1 (ru) 2002-10-31
ME00568A (en) 2011-12-20
CZ297780B6 (cs) 2007-03-28
ME00568B (me) 2011-12-20
KR20020060205A (ko) 2002-07-16
AU776587B2 (en) 2004-09-16
NO20021866D0 (no) 2002-04-19
ZA200203078B (en) 2003-01-29
CO5251406A1 (es) 2003-02-28
HK1051003A1 (en) 2003-07-18
PL356190A1 (en) 2004-06-14
TWI269655B (en) 2007-01-01
PL197537B1 (pl) 2008-04-30
BG65799B1 (bg) 2009-12-31
KR100705372B1 (ko) 2007-04-11
MY121175A (en) 2005-12-30
NZ518299A (en) 2004-03-26
US8383611B1 (en) 2013-02-26
AR026073A1 (es) 2002-12-26
NO20021866L (no) 2002-04-19
WO2001028563A1 (en) 2001-04-26
CN1379673A (zh) 2002-11-13
BG106517A (en) 2002-12-29
ES2223595T3 (es) 2005-03-01
DE60011924D1 (de) 2004-08-05
DE60011924T2 (de) 2005-07-07
HUP0203756A3 (en) 2004-06-28
HRP20020345A2 (en) 2005-10-31
HU228894B1 (hu) 2013-06-28
AU7953200A (en) 2001-04-30
CA2388325A1 (en) 2001-04-26
PE20010713A1 (es) 2001-07-13
JP4856338B2 (ja) 2012-01-18
HUP0203756A2 (en) 2003-05-28

Similar Documents

Publication Publication Date Title
ATE389019T1 (de) Interleukin-12 p40 und interleukin-b30. kombinationen davon. antikörper. verwendungen in pharmazeutische zusammensetzungen
DE60004052D1 (de) Pharmazeutische zubereitungen auf der basis von levodopa, carbidopa und entacapone
DE60226613D1 (de) Darreichungsformen welche mikropartikel und treibgas enthalten
AP2002002558A0 (en) Pharmaceutical compositions containing polymer and drug assemblies.
NO20022998D0 (no) Farmasöytiske preparater som tilveiebringer foröket konsentrasjon av medikament
RU2002109814A (ru) Новые производные аминодикарбоновых кислот, обладающие фармацевтическими свойствами
FI964681A0 (fi) Ihmisperäiset Lactobacillus-kannat, niitä sisältävät valmisteet ja niiden käytöt
DE60108154D1 (de) Pharmazeutische Zubereitungen enthaltend Clavulansäure
DE69928260D1 (de) Schwefel-substituierte sulfonylaminocarbonsäure n-arylamide, ihre herstellung, ihre anwendung und diese enthaltende pharmazeutische zusammensetzungen
DE69931925D1 (de) 2-chinolonen enthaltende arzneimittel
BR9801652A (pt) Resorcinil-triazinas
HRP20020345B1 (en) Ciclesonide-containing aqueous pharmaceutical composition
ATE214610T1 (de) Neuartige pharmazeutische verwendungen von krill- enzymen
RS49764B (sr) Farmaceutski preparat za primenu na mukozu
FR2805465B1 (fr) Nouvelles compositions pharmaceutique ou dietetiques a base de champignons
BR9711046A (pt) Ligando relacionado a fator de necrose de tumor.
ATE297223T1 (de) Teilchenförmige vitaminzubereitung
DE69831703D1 (de) Wasserhaltige Granulate von Hydrolysaten eines Ethylen-Vinylazetatpolymeren, ihre Herstellung und damit hergestellte Gegenstände
TR200001102T2 (tr) İkameli tetrahidropirimidinen türevleri, üretimleri ve kullanımları.
SE0001916D0 (sv) Novel formulation
BR0206960A (pt) Composição farmacêutica oral, e, uso de um polìmero de ftalato de hidroxipropilmetilcelulose
FR2779429B1 (fr) Derives d'oxindole, leurs preparations et leurs applications en therapeutique
BR0210096A (pt) Composição farmacêutica contendo emoliente de fezes tal como poloxâmero e partìculas entéricas revestidas de bissacodil
YU39396A (sh) Upotreba izolovanog prirodnog proteina gojaznosti za pripremu leka i njegova farmaceutska formulacija
WO2001022917A8 (en) Effervescent compositions comprising nimesulide

Legal Events

Date Code Title Description
A1OB Publication of a patent application
ARAI Request for the grant of a patent on the basis of the submitted results of a substantive examination of a patent application
B1PR Patent granted
PNAN Change of the applicant name, address/residence

Owner name: NYCOMED GMBH, DE

PNAN Change of the applicant name, address/residence

Owner name: TAKEDA GMBH, DE

PNAN Change of the applicant name, address/residence

Owner name: NYCOMED ASSET MANAGEMENT GMBH, DE

Owner name: TAKEDA GMBH, DE

Owner name: NYCOMED GERMANY HOLDING GMBH, DE

PPPP Transfer of rights

Owner name: ASTRAZENECA AB, SE

PPPP Transfer of rights

Owner name: COVIS PHARMA B.V., CH

ODRP Renewal fee for the maintenance of a patent

Payment date: 20190828

Year of fee payment: 20

PB20 Patent expired after termination of 20 years

Effective date: 20201020